International Consensus on Antinuclear Antibody Patterns: defining negative results and reporting unidentified patterns

Articles in the same Issue

1. Frontmatter
2. Editorials
3. Harmonization in laboratory medicine: Blowin’ in the wind
4. Standardization and harmonization of autoimmune diagnostics
5. On the complexity of hemostasis and the need for harmonization of test practice
6. Harmonization of laboratory hematology: a long and winding journey
7. Section 1: Current Harmonization Activities at Global Level
8. Harmonization in laboratory medicine: more than clinical chemistry?
9. Harmonization of External Quality Assessment Schemes and their role – clinical chemistry and beyond
10. An overview of EFLM harmonization activities in Europe
11. Metrological traceability and harmonization of medical tests: a quantum leap forward is needed to keep pace with globalization and stringent IVD-regulations in the 21st century!
12. Assessment of bone turnover in osteoporosis: harmonization of the total testing process
13. Recent initiatives in harmonization of hemostasis practice
14. EASI – European Autoimmunity Standardisation Initiative: facing the challenges of diagnostics in autoimmunity
15. Harmonization of microbiology processes and standards: work in progress
16. Harmonization initiatives in the generation, reporting and application of biological variation data
17. Harmonization of accreditation to ISO15189
18. External quality assessment programs in the context of ISO 15189 accreditation
19. Section 2: Pre-Pre and Pre-Analytical Phase
20. Laboratory testing in the emergency department: an Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report
21. The EFLM strategy for harmonization of the preanalytical phase
22. Section 3: The Analytical Phase
23. The roadmap for harmonization: status of the International Consortium for Harmonization of Clinical Laboratory Results
24. The quest for equivalence of test results: the pilgrimage of the Dutch Calibration 2.000 program for metrological traceability
25. Current state and recommendations for harmonization of serum/plasma 17-hydroxyprogesterone mass spectrometry methods
26. International normalized ratio (INR) testing in Europe: between-laboratory comparability of test results obtained by Quick and Owren reagents
27. Detecting molecular forms of antithrombin by LC-MRM-MS: defining the measurands
28. A design for external quality assessment for the analysis of thiopurine drugs: pitfalls and opportunities
29. Harmonization of PCR-based detection of intestinal pathogens: experiences from the Dutch external quality assessment scheme on molecular diagnosis of protozoa in stool samples
30. Harmonization of urine albumin/creatinine ratio (ACR) results: a study based on an external quality assessment program in Polish laboratories
31. Standardization of autoimmune testing – is it feasible?
32. Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization
33. Clinically relevant discrepancies between different rheumatoid factor assays
34. An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice
35. Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies
36. Harmonization in autoimmune thyroid disease diagnostics
37. International consensus on antinuclear antibody patterns: definition of the AC-29 pattern associated with antibodies to DNA topoisomerase I
38. Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies
39. International Consensus on Antinuclear Antibody Patterns: defining negative results and reporting unidentified patterns